Read + Share
Aroldi F, Elez E, Andre T, Perkins G, et al. A Phase Ia/b study of MEK1/2 inhibitor binimetinib with MET inhibitor crizotinib
in patients with RAS mutant advanced colorectal cancer (MErCuRIC). BMC Cancer 2025;25:658.
PMID: 40211189
|
 |
|
Aroldi F, Elez E, Andre T, Perkins G, et al. A Phase Ia/b study of MEK1/2 inhibitor binimetinib with MET inhibitor crizotinib
in patients with RAS mutant advanced colorectal cancer (MErCuRIC). BMC Cancer 2025;25:658.
PMID: 40211189
|
|
|
|